(From the August 2022 Issue of MedStat) New Homecare Pharmacy: Supporting Best Care In the May issue of MedStat, Homecare highlighted the growth among its many service lines due to increased demands for pediatric home care in central Ohio and beyond. One area which has grown and changed significantly is Homecare’s Infusion Pharmacy services. The construction of a new Infusion Pharmacy suite began in 2020 and was completed in the first quarter of 2022. This new suite is more than three times the size of the former space to support the growing referral demands for in-home infusion services. Homecare Pharmacy referrals increased by more than 10,000 between 2020 and 2021, with more than 86,000 referrals in 2020 to more than 98,000 in 2021. Receiving scheduled infusions at home can decrease travel and anxiety for the patient and family, resulting in increased quality of life for the patient. Homecare Pharmacy works integrally with the hospital’s inpatient unit teams to provide a continuum of care for pediatric patients and to support their complex or long-term health care needs at home. Homecare pediatric medications range from simple injectables to more complex IV infusions and may include therapies such as enzyme replacement and gene modifying agents, TPN, antibiotics, chemotherapy, pain management or monoclonal antibodies. Pharmacy’s Hemophilia Factor Program is just one example of how the Homecare Pharmacy staff works integrally with the hospital’s Hemophilia Treatment Center (HTC) to support hemophilia patients and families in managing the disease. Homecare’s pharmacy factor care coordinator works with the child’s inpatient HTC team and the family to ensure medications and supplies are always there for the patient. The goal is to return each child to the most normal and pain-free life possible. View the video tour of the Infusion Pharmacy suite. To learn more about all of Homecare’s service lines, click here. If you have questions about Homecare Infusion Pharmacy or any of Homecare’s services, email Carolyn Figi.
(From the August 2022 Issue of MedStat) New Homecare Pharmacy: Supporting Best Care In the May issue of MedStat, Homecare highlighted the growth among its many service lines due to increased demands for pediatric home care in central Ohio and beyond. One area which has grown and changed significantly is Homecare’s Infusion Pharmacy services. The construction of a new Infusion Pharmacy suite began in 2020 and was completed in the first quarter of 2022. This new suite is more than three times the size of the former space to support the growing referral demands for in-home infusion services. Homecare Pharmacy referrals increased by more than 10,000 between 2020 and 2021, with more than 86,000 referrals in 2020 to more than 98,000 in 2021. Receiving scheduled infusions at home can decrease travel and anxiety for the patient and family, resulting in increased quality of life for the patient. Homecare Pharmacy works integrally with the hospital’s inpatient unit teams to provide a continuum of care for pediatric patients and to support their complex or long-term health care needs at home. Homecare pediatric medications range from simple injectables to more complex IV infusions and may include therapies such as enzyme replacement and gene modifying agents, TPN, antibiotics, chemotherapy, pain management or monoclonal antibodies. Pharmacy’s Hemophilia Factor Program is just one example of how the Homecare Pharmacy staff works integrally with the hospital’s Hemophilia Treatment Center (HTC) to support hemophilia patients and families in managing the disease. Homecare’s pharmacy factor care coordinator works with the child’s inpatient HTC team and the family to ensure medications and supplies are always there for the patient. The goal is to return each child to the most normal and pain-free life possible. View the video tour of the Infusion Pharmacy suite. To learn more about all of Homecare’s service lines, click here. If you have questions about Homecare Infusion Pharmacy or any of Homecare’s services, email Carolyn Figi.
(From the August 2022 Issue of MedStat) New Homecare Pharmacy: Supporting Best Care In the May issue of MedStat, Homecare highlighted the growth among its many service lines due to increased demands for pediatric home care in central Ohio and beyond. One area which has grown and changed significantly is Homecare’s Infusion Pharmacy services. The construction of a new Infusion Pharmacy suite began in 2020 and was completed in the first quarter of 2022. This new suite is more than three times the size of the former space to support the growing referral demands for in-home infusion services. Homecare Pharmacy referrals increased by more than 10,000 between 2020 and 2021, with more than 86,000 referrals in 2020 to more than 98,000 in 2021. Receiving scheduled infusions at home can decrease travel and anxiety for the patient and family, resulting in increased quality of life for the patient. Homecare Pharmacy works integrally with the hospital’s inpatient unit teams to provide a continuum of care for pediatric patients and to support their complex or long-term health care needs at home. Homecare pediatric medications range from simple injectables to more complex IV infusions and may include therapies such as enzyme replacement and gene modifying agents, TPN, antibiotics, chemotherapy, pain management or monoclonal antibodies. Pharmacy’s Hemophilia Factor Program is just one example of how the Homecare Pharmacy staff works integrally with the hospital’s Hemophilia Treatment Center (HTC) to support hemophilia patients and families in managing the disease. Homecare’s pharmacy factor care coordinator works with the child’s inpatient HTC team and the family to ensure medications and supplies are always there for the patient. The goal is to return each child to the most normal and pain-free life possible. View the video tour of the Infusion Pharmacy suite. To learn more about all of Homecare’s service lines, click here. If you have questions about Homecare Infusion Pharmacy or any of Homecare’s services, email Carolyn Figi.
(From the August 2022 Issue of MedStat)
New Homecare Pharmacy: Supporting Best Care
In the May issue of MedStat, Homecare highlighted the growth among its many service lines due to increased demands for pediatric home care in central Ohio and beyond. One area which has grown and changed significantly is Homecare’s Infusion Pharmacy services. The construction of a new Infusion Pharmacy suite began in 2020 and was completed in the first quarter of 2022.
This new suite is more than three times the size of the former space to support the growing referral demands for in-home infusion services. Homecare Pharmacy referrals increased by more than 10,000 between 2020 and 2021, with more than 86,000 referrals in 2020 to more than 98,000 in 2021. Receiving scheduled infusions at home can decrease travel and anxiety for the patient and family, resulting in increased quality of life for the patient.
Homecare Pharmacy works integrally with the hospital’s inpatient unit teams to provide a continuum of care for pediatric patients and to support their complex or long-term health care needs at home. Homecare pediatric medications range from simple injectables to more complex IV infusions and may include therapies such as enzyme replacement and gene modifying agents, TPN, antibiotics, chemotherapy, pain management or monoclonal antibodies.
Pharmacy’s Hemophilia Factor Program is just one example of how the Homecare Pharmacy staff works integrally with the hospital’s Hemophilia Treatment Center (HTC) to support hemophilia patients and families in managing the disease. Homecare’s pharmacy factor care coordinator works with the child’s inpatient HTC team and the family to ensure medications and supplies are always there for the patient. The goal is to return each child to the most normal and pain-free life possible. View the video tour of the Infusion Pharmacy suite.
To learn more about all of Homecare’s service lines, click here. If you have questions about Homecare Infusion Pharmacy or any of Homecare’s services, email Carolyn Figi.